New test improves diagnosis of a common genetic cause of autism

October 28, 2019

A new DNA test for Fragile X syndrome has been shown to have accuracy and specificity approaching 100 per cent

Read more

Lineagen and PWNHealth Partner to Expand Access to Genetic Testing Solutions for the Autism Spectrum Disorder and Neurodevelopmental Disorder Communities

January 10, 2019

Lineagen is partnering with PWNHealth to expand access to its clinical genetic tests.

Read more

Michael Paul, Ph.D., CEO of Lineagen, Inc., Nominated for Prestigious Entrepreneur of the Year Award

May 14, 2018

EY (Ernst & Young) Award recognizes entrepreneurs “…whose boldness drives them to do things differently and change our world in the most unexpected ways.”

Read more

Lineagen, Inc. Named to MountainWest Capital Network's 2017 Utah 100

November 8, 2017

Lineagen was named to the 2017 Utah 100, MountainWest Capital Network’s (MWCN) annual list of the fastest-growing companies in Utah.

Read more

Lineagen Announces Launch of Proprietary Variant Index to Improve Interpretation of Genetic Basis for Childhood Developmental Delay

October 19, 2016

Lineagen, Inc. announced today the presentation at annual meeting of the American Society of Human Genetics (ASHG) and commercial launch of a Proprietary Variant Index
 

Read more